Literature DB >> 27240772

Structural analysis of lead magnesium niobate using synchrotron powder X-ray diffraction and the Rietveld method.

Ashok Bhakar1, Adityanarayan H Pandey2, M N Singh1, Anuj Upadhyay1, A K Sinha1, S M Gupta2, Tapas Ganguli1.   

Abstract

The room-temperature synchrotron powder X-ray diffraction pattern of the single phase perovskite lead magnesium niobate (PMN) has shown significant broadening in the q range ∼ 5-7 Å(-1) compared with standard LaB6 synchrotron powder X-ray diffraction data, taken under similar conditions. This broadening/asymmetry lies mainly towards the lower 2θ side of the Bragg peaks. Attempts to fit this data with the paraelectric cubic phase (Pm\bar 3m) and the local rhombohedral phase (R3m) corresponding to polar nanoregions (PNRs) are made using the Rietveld method. Rietveld refinements show that neither cubic (Pm\bar 3m) nor rhombohedral (R3m) symmetry can fit this XRD pattern satisfactorily. The two-phase refinement fits the experimental data satisfactorily and suggests that the weight percentage of the PNRs is approximately 12-16% at room temperature. The unit-cell volume of these rhombohedral PNRs is approximately 0.15% larger than that of the unit cell volume of the paraelectric cubic phase.

Entities:  

Keywords:  Rietveld method; lead magnesium niobate; polar nanoregions; powder diffraction; relaxor ceramic

Year:  2016        PMID: 27240772     DOI: 10.1107/S2052520616006508

Source DB:  PubMed          Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater        ISSN: 2052-5192


  1 in total

1.  One Site, Two Cations, Three Environments: s2 and s0 Electronic Configurations Generate Pb-Free Relaxor Behavior in a Perovskite Oxide.

Authors:  T Wesley Surta; Thomas A Whittle; Matthew A Wright; Hongjun Niu; Jacinthe Gamon; Quinn D Gibson; Luke M Daniels; William J Thomas; Marco Zanella; Philippa M Shepley; Yang Li; Anton Goetzee-Barral; Andrew J Bell; Jonathan Alaria; John B Claridge; Matthew J Rosseinsky
Journal:  J Am Chem Soc       Date:  2021-01-14       Impact factor: 15.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.